Tatva Chintan Pharma Chem

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue114.61120.19107.1393.3387.28
Expenses101.45109.7195.4081.6280.72
EBITDA17.9216.1920.6321.5013.52
EBIT15.5310.0714.6214.726.94
Profit Before Tax13.166.8911.7211.706.56
Net Profit10.5616.158.258.204.65
Financial Ratios
Operating Profit Margin15.78%10.55%19.44%23.23%15.71%
Net Profit Margin9.30%16.53%7.77%8.86%5.40%
Earning Per Share (Diluted)4.767.293.723.631.99
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ